TScan Therapeutics
TCRX
TCRX
28 hedge funds and large institutions have $20.3M invested in TScan Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$1.15M | |
2 | +$187K | |
3 | +$64.6K | |
4 |
State Street
Boston,
Massachusetts
|
+$22.3K |
5 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
+$21K |
Top Sellers
1 | -$798K | |
2 | -$31K | |
3 | -$20.9K | |
4 |
LPL Financial
San Diego,
California
|
-$10.5K |
5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.58K |